Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TIVA vs Inhalational Anesthesia in Endoscopic Tympanoplasty
NCT05993039Phase 1Unknown
- Sponsor
- Our Lady of the Lake Regional Medical Center
- Start
- Sep 2023
- Primary completion
- Dec 2024
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of propofol and remifentanil in tympanic membrane perforation (2 arms), sponsored by Our Lady of the Lake Regional Medical Center. Primary endpoints: Surgical Field Quality and Intra-operative blood loss. Status: unknown.
02
Drugs
propofolremifentanil
03
Conditions
tympanic membrane perforation
Beyond the preview
Go deeper on NCT05993039.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05993039.